Palbociclib renders human papilloma virus–negative head and neck squamous cell carcinoma vulnerable to the senolytic agent navitoclax

Nicholas J. Gadsden, Cory D. Fulcher, Daniel Li, Nitisha Shrivastava, Carlos Thomas, Jeffrey E. Segall, Michael B. Prystowsky, Nicolas F. Schlecht, Evripidis Gavathiotis, Thomas J. Ow

Research output: Contribution to journal › Article › peer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'Palbociclib renders human papilloma virus–negative head and neck squamous cell carcinoma vulnerable to the senolytic agent navitoclax'. Together they form a unique fingerprint.

Medicine & Life Sciences